Biogen, Eisai’s Alzheimer’s drug aducanumab makes history with US approval
First new treatment approved for Alzheimer’s disease in over a decade
Read More
Tag: Aduhelm
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
